Get started
Author

Rune Slot Thing

Observed names: R S Thing, R. Slot Thing, R. Thing, R.S. Thing, Rune S. Thing, Rune Thing, Slot Thing, Rune
Institution: Lillebaelt Hospital
Observed institutions: University of Vermont, University of Southern Denmark, University of Canterbury, Cracow University of Technology, Odense University Hospital, University of Vermont Medical Center, Vejle Sygehus, Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda, Region of Southern Denmark, Hygeia Hospital, Lillebaelt Hospital
ORCID: 0000-0002-2683-2847
Observed ORCID: 0000-0002-2683-2847
OpenAlex ID: A5049725712
Hounsfield unit recovery in clinical cone beam CT images of the thorax acquired for image guided radiation therapy
2016 · Rune Slot Thing, Uffe Bernchou, et al. · Physics in Medicine and Biology · 49
PDF
Accuracy of dose calculation based on artefact corrected Cone Beam CT images of lung cancer patients
2017 · Rune Slot Thing, Uffe Bernchou, et al. · Physics and Imaging in Radiation Oncology · 42
PDF
Evaluation of CBCT based dose calculation in the thorax and pelvis using two generic algorithms
2022 · R.S. Thing, R. Nilsson, et al. · Physica Medica · 41
PDF
Patient-specific scatter correction in clinical cone beam computed tomography imaging made possible by the combination of Monte Carlo simulations and a ray tracing algorithm
2013 · Rune S. Thing, Uffe Bernchou, et al. · Acta Oncologica · 31
PDF
Thorough design and pre-trial quality assurance (QA) decrease dosimetric impact of delineation and dose planning variability in the STRICTLUNG and STARLUNG trials for stereotactic body radiotherapy (SBRT) of central and ultra-central lung tumours
2022 · L. Hoffmann, G.F. Persson, et al. · Radiotherapy and Oncology · 20
PDF
Optimizing cone beam CT scatter estimation in egs_cbct for a clinical and virtual chest phantom
2014 · Rune Slot Thing, Ernesto Mainegra-Hing · Medical Physics · 20
PDF
Does coronary artery calcium score have an impact on overall survival for locally advanced non-small cell lung cancer treated with definitive radiotherapy
2023 · Agon Olloni, Carsten Brink, et al. · Radiotherapy and Oncology · 17
PDF
Heart and Lung Dose as Predictors of Overall Survival in Patients With Locally Advanced Lung Cancer. A National Multicenter Study
2024 · Agon Olloni, Carsten Brink, et al. · JTO Clinical and Research Reports · 12
Toxicity Within 6 Months of Heterogeneous Fluorodeoxyglucose-Guided Radiotherapy Dose Escalation for Locally Advanced Non–Small Cell Lung Cancer in the Scandinavian Randomized Phase III NARLAL2 Trial
2025 · Tine Schytte, Marianne M. Knap, et al. · Journal of Clinical Oncology · 9
An open source auto-segmentation algorithm for delineating heart and substructures – Development and validation within a multicenter lung cancer cohort
2023 · Agon Olloni, Ebbe Laugaard Lorenzen, et al. · Radiotherapy and Oncology · 8
Robust optimization of the Gross Tumor Volume compared to conventional Planning Target Volume-based planning in photon Stereotactic Body Radiation Therapy of lung tumors
2024 · Thomas L. Fink, Charlotte Kristiansen, et al. · Acta Oncologica · 5
Monte Carlo validation of optimal material discrimination using spectral x-ray imaging
2014 · S J Nik, R S Thing, et al. · Journal of Instrumentation · 3
PDF
The prognostic value of methylated ctDNA, soluble PD-L1, and NK-cell activity on the risk of relapse after curative radiotherapy of non-small cell lung cancer
2026 · Thomas Leth Fink, Rikke Fredslund Andersen, et al. · Clinical & Translational Oncology · 1
Enhancing patient engagement: the influence of an in-consult patient decision aid on shared decision-making for lung tumour radiation – protocol for the randomised trial ‘SDM Lung SBRT’
2025 · Thomas Leth Fink, Torben Frøstrup Hansen, et al. · BMJ Open · 1
PDF
3531: The NARLAL II trial: First results on loco-regional control in stage 3 NSCLC
2024 · Tine Schytte, Charlotte Kristiansen, et al. · Radiotherapy and Oncology · 1
2414 Online adaptive palliative radiotherapy on a standard linac without a dedicated planning CT – first experiences from the Rapid Care trial
2025 · Rune S. Thing, Charlotte Kristiansen, et al. · Radiotherapy and Oncology
3314 Dosimetric effects of respiratory and anatomical changes in the European PROTECT trial: Proton vs photon therapy in locally advanced esophageal cancer
2025 · Sarah Eckholdt Jensen, Hanna Rahbek Mortensen, et al. · Radiotherapy and Oncology
959: Whole brain radiotherapy for palliative patients: Are we doing our best?
2024 · Charlotte Kristiansen, Julie Stougaard, et al. · Radiotherapy and Oncology
2220: Robust optimization of the GTV is able to reduce normal tissue irradiation in lung SBRT
2024 · Thomas L. Fink, Charlotte Kristiansen, et al. · Radiotherapy and Oncology
2381: Inhomogeneous dose escalation for NSCLC: Full dosimetric analysis of the phase III NARLAL2 trial
2024 · Christina M. Lutz, Tine B. Nielsen, et al. · Radiotherapy and Oncology
1458: Characterization of a solid water material for true end-to-end testing
2024 · Rune S. Thing, Bjarke Mortensen, et al. · Radiotherapy and Oncology
1082: Fractionation in palliative radiotherapy for bone metastases – 5 years of experience in one hospital
2024 · Christine Vestergaard Madsen, Rune Slot Thing, et al. · Radiotherapy and Oncology
2014: Online adaptive VMAT radiotherapy of bone metastases based on a diagnostic CT and a standard linac
2024 · Rune S. Thing, Charlotte Kristiansen, et al. · Radiotherapy and Oncology
2661: CBCT-based calculation of the dose to target for all fractions in prostate cancer radiotherapy
2024 · Rasmus Havelund, Martin Berg, et al. · Radiotherapy and Oncology
PO-1831 Heterogeneously Hypo-fractionated RT for LA-NSCLC (the HERAN trial): Clinical treatment plan results
2023 · L. Hoffmann, A. Appelt, et al. · Radiotherapy and Oncology
Works count: 47
Citation count: 260
H-index: 9
I10-index: 8
Year
Topic
Type